FAN; Timothy M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for FAN; Timothy M..The latest application filed is for "saliva-based molecular testing for sars-cov-2".
- FAN; Timothy M. - Mahomet IL
| Patent | Date |
|---|---|
| Saliva-based Molecular Testing For Sars-cov-2 App 20220275464 - RANOA; Diana Rose ; et al. | 2022-09-01 |
| Procaspase-3 Activation And Immunotherapy For Treatment Of Cancer App 20220226311 - HERGENROTHER; Paul J. ; et al. | 2022-07-21 |
| Saliva-based Molecular Testing For Sars-cov-2 App 20210395839 - RANOA; Diana Rose ; et al. | 2021-12-23 |
| Imidazotetrazine Compounds App 20210315886 - HERGENROTHER; Paul J. ; et al. | 2021-10-14 |
| Procaspase Combination Therapy For Glioblastoma App 20210290616 - Hergenrother; Paul J. ; et al. | 2021-09-23 |
| Procaspase 3 Activation By Combination Therapy App 20210128551 - HERGENROTHER; Paul J. ; et al. | 2021-05-06 |
| Procaspase 3 activation by combination therapy Grant 10,888,560 - Hergenrother , et al. January 12, 2 | 2021-01-12 |
| Imidazotetrazine Compounds App 20210002286 - HERGENROTHER; Paul J. ; et al. | 2021-01-07 |
| Procaspase combination therapy for glioblastoma Grant 10,874,666 - Hergenrother , et al. December 29, 2 | 2020-12-29 |
| Procaspase Combination Therapy For Glioblastoma App 20190099419 - HERGENROTHER; Paul J. ; et al. | 2019-04-04 |
| Procaspase 3 Activation By Combination Therapy App 20190099418 - HERGENROTHER; Paul J. ; et al. | 2019-04-04 |
| Procaspase 3 activation by combination therapy Grant 10,085,977 - Hergenrother , et al. October 2, 2 | 2018-10-02 |
| Procaspase combination therapy for glioblastoma Grant 10,085,978 - Hergenrother , et al. October 2, 2 | 2018-10-02 |
| Procaspase activating compounds Grant 9,643,960 - Hergenrother , et al. May 9, 2 | 2017-05-09 |
| Potent anticancer activity via dual compound activation Grant 9,592,229 - Hergenrother , et al. March 14, 2 | 2017-03-14 |
| Procaspase Combination Therapy For Glioblastoma App 20170042886 - HERGENROTHER; Paul J. ; et al. | 2017-02-16 |
| Procaspase 3 Activation By Combination Therapy App 20160346277 - HERGENROTHER; Paul J. ; et al. | 2016-12-01 |
| Procaspase combination therapy for glioblastoma Grant 9,421,202 - Hergenrother , et al. August 23, 2 | 2016-08-23 |
| Procaspase 3 activation by combination therapy Grant 9,399,035 - Hergenrother , et al. July 26, 2 | 2016-07-26 |
| Procaspase Activating Compounds App 20150344452 - Hergenrother; Paul J. ; et al. | 2015-12-03 |
| Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs Grant 9,102,661 - Hergenrother , et al. August 11, 2 | 2015-08-11 |
| Potent Anticancer Activity Via Dual Compound Activation App 20150099759 - Hergenrother; Paul J. ; et al. | 2015-04-09 |
| Procaspase Combination Therapy For Glioblastoma App 20150025083 - Hergenrother; Paul J. ; et al. | 2015-01-22 |
| Procaspase 3 Activation By Combination Therapy App 20150017264 - Hergenrother; Paul J. ; et al. | 2015-01-15 |
| Design, Synthesis And Evaluation Of Procaspase Activating Compounds As Personalized Anti-cancer Drugs App 20140315915 - Hergenrother; Paul J. ; et al. | 2014-10-23 |
| Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs Grant 8,778,945 - Hergenrother , et al. July 15, 2 | 2014-07-15 |
| Design, Synthesis And Evaluation Of Procaspase Activating Compounds As Personalized Anti-cancer Drugs App 20120040995 - Hergenrother; Paul J. ; et al. | 2012-02-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 